The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Important Update on FDA Changes Concerning Peptides Ipamorelin (RUO) Selective GHS R1a Agonist USA Supplier Mounjaro Approved for Children 10+ With Type 2 Diabetes Benefits, Side Effects & Insurance Coverage